SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 6, 1996
COPLEY PHARMACEUTICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
0-20126 04-2514637
(Commission File Number) (IRS Employer Identification No.)
25 John Road
Canton, Massachusetts 02021
(Address of principal executive offices) (Zip Code)
(617) 821-6111
(Registrant's telephone number, including area code)
<PAGE 2>
Item 5. Other Events
On September 6, 1996, Copley Pharmaceutical, Inc. (the "Company")
announced that Ken E. Starkweather has accepted the position of Vice
President - Finance, succeeding Barbara Sherrill, who has resigned all
positions in the Company for personal reasons.
Mr. Starkweather comes to Copley from Hoechst Marion Roussel, Inc.
During a 21-year career at Hoechst Marion Roussel, Marion Merrell Dow, and
Dow Chemical Company, he held several senior financial management positions.
Most recently he has been Director of Procurement for US operations; prior to
that he was Director of Finance, Pacific Area, where he directed all
accounting, tax and treasury activities for Marion Merrell Dow activities in
Japan, Australia, New Zealand, Korea and China.
<PAGE 3>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
September 10, 1996
COPLEY PHARMACEUTICAL, INC.
/s/ Kenneth N. Larsen
______________________________
Kenneth N. Larsen
President and Chairman
